Bruker (BRKR) Current Deferred Revenue (2010 - 2026)

Bruker's Current Deferred Revenue history runs 17 years deep, the most recent figure standing at $586.1 million for Q1 2026.

• Quarterly Current Deferred Revenue rose 24.54% year-over-year to $586.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $586.1 million (up 24.54% YoY) and the FY2025 annual result came in at $550.4 million, up 25.6% from the prior year.
• Current Deferred Revenue was $586.1 million for Q1 2026 at Bruker, up from $550.4 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $590.8 million in Q1 2024 and bottomed at $175.5 million in Q3 2022.
• A 5-year average of $462.7 million and a median of $467.9 million in 2022 frame the typical range for Current Deferred Revenue.
• Peak annual rise in Current Deferred Revenue reached 156.81% in 2022, while the deepest fall reached 56.19% in 2022.
• Bruker's Current Deferred Revenue stood at $370.2 million in 2022, then surged by 32.74% to $491.4 million in 2023, then declined by 10.83% to $438.2 million in 2024, then advanced by 25.6% to $550.4 million in 2025, then rose by 6.49% to $586.1 million in 2026.
• Business Quant data shows BRKR's Current Deferred Revenue at $586.1 million in Q1 2026, $550.4 million in Q4 2025, and $562.2 million in Q3 2025.